Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2005-04-05
2005-04-05
Riley, Jezia (Department: 1637)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120, C435S091100, C435S091200, C536S023100, C536S024330
Reexamination Certificate
active
06875593
ABSTRACT:
Novel oligomers are disclosed which have enhanced ability with respect to forming duplexes or triplexes compared with oligomers containing only conventional bases. The oligomers contain the bases 5-(1-propynyl)uracil, 5-(1-propynyl)cytosine or related analogs. The oligomers of the invention are capable of (i) forming triplexes with various target sequences such as virus or oncogene sequences by coupling into the major groove of a target DNA duplex at physiological pH or (ii) forming duplexes by binding to single-stranded DNA or to RNA encoded by target genes. The oligomers of the invention can be incorporated into pharmaceutically acceptable carriers and can be constructed to have any desired sequence, provided the sequence normally includes one or more bases that is replaced with the analogs of the invention. Compositions of the invention can be used as pharmaceutical agents to treat various diseases such as those caused by viruses and can be used for diagnostic purposes in order to detect viruses or disease conditions.
REFERENCES:
patent: 4415732 (1983-11-01), Caruthers et al.
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 4725677 (1988-02-01), Köster et al.
patent: 4904582 (1990-02-01), Tullis
patent: 4959463 (1990-09-01), Froehler et al.
patent: 5013830 (1991-05-01), Ohtsuka et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5204455 (1993-04-01), Froehler et al.
patent: 5256775 (1993-10-01), Froehler
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5264564 (1993-11-01), Matteucci
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5399676 (1995-03-01), Froehler
patent: 5440040 (1995-08-01), Gronowitz
patent: 5466786 (1995-11-01), Buhr et al.
patent: 5484908 (1996-01-01), Froehler et al.
patent: 5495009 (1996-02-01), Matteucci et al.
patent: 5596086 (1997-01-01), Matteucci et al.
patent: 5840867 (1998-11-01), Toole et al.
patent: 6380368 (2002-04-01), Froehler et al.
patent: 1311201 (1992-12-01), None
patent: 0 486 477 (1987-12-01), None
patent: 0 251 786 (1988-01-01), None
patent: 0 269 574 (1988-06-01), None
patent: 0 286 028 (1988-10-01), None
patent: 0 375 408 (1990-06-01), None
patent: 0 415 901 (1991-03-01), None
patent: 0 492 570 (1991-12-01), None
patent: WO 8808001 (1988-10-01), None
patent: WO 8912060 (1989-12-01), None
patent: WO 8912061 (1989-12-01), None
patent: WO 9006934 (1990-06-01), None
patent: WO 9015884 (1990-12-01), None
patent: WO 9106626 (1991-05-01), None
patent: WO 9202258 (1992-02-01), None
patent: WO 9205186 (1992-04-01), None
patent: WO 9206102 (1992-04-01), None
patent: WO 9209705 (1992-06-01), None
patent: WO 9210590 (1992-06-01), None
Albretsen, et al., “Optimal conditions for hybridization with oligonucleotides: A study with myc-oncogene DNA probes,”Anal. Biochem.,1988, 170, 193-202.
Augustyns, et al., “Incorporation of hexose nucleoside analogues into oligonucleotides: synthesis, based-pairing properties and enzymatic stability,”Nuc. Acids Res.,1992, 20, 4711-4716.
Balzarini, et al., “Incorporation of 5-substituted pyrimidine nucleoside analogs into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line,”Chem. Ab.,1985, 103(3), 16283a.
Beal, et al., “Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation,”Science,1990, 251, 1360-1363.
Capobianco, et al., “One pot solution synthesis of cyclic oligodeoxyribonucleotides,”Nuc. Acids Res.,1990, 18, 2661-2669.
Casey, et al., “Rates of formation and thermal stabilities of RNA-DNA duplexes at high concentration of formamide,”Nuc. Acids Res.,1997, 4(5), 1539-1552.
Chiang, et al., “Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms,”J. Bio. Chem.,1991, 266, 18162-18171.
Civio, et al., “Synthesis of dinucleoside phosphates containing sulfur substituted nucleobase: 4-thiouracil, 4-thiothymine and 6-mercaptopurine,”Tet. Letts.,1992, 33, 69-72.
Connolly, et al., “Synthesis and properties of oligonucleotides containing 4-thiothymidine, 5-methyl-2-pyrimidinone-1-b-D(2′-deoxyriboside) and 2-thiothymidine,”Nuc. Acids Res.,1989, 17, 4957-4974.
Cooney, et al., “Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro,”Science,1988, 241, 456-459.
De Clercq, et al., “Nucleic acid related compounds. 40. Synthesis and biological activities of 5-alkynyluracil nucleosides,”J. Med. Chem.,1983, 26, 661-666.
Egholm, et la., “Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone,”J. Am. Chem. Soc.,1992, 114, 1895-1897.
Fedorovo, et al., “Complementary addressed modification of double-stranded DNA within a ternary complex,”FEBS,1988, 228, 273-276.
Felgner, et al., “Lipofection: a highly efficient, liqid-mediated DNA-transfection procedure,”Proc. Natl. Acad. Sci.,1987, 84, 7413-7417.
Froehler, et al., “Oligodeoxynucleotides containing C-5 propyne analogs of 2′-deoxyuridine and 2′-deoxycytidine,”Tet. Letts.,1992, 33, 5307-5310.
Froehler, et al., “Triple-helix formation and cooperative binding by oligodeoxynucleotides with a 3′-3′ internucleotide junction,”Biochem.,1992, 31, 1603-1609.
Froehler, et al., “Triple-helix formation by oligodeoxynucleotides containing the carbocyclic analogs of thymidine and 5-methyl-2′-deoxycytidine,”J. Am. Chem. Soc.,1992, 114, 8320-8322.
Goodchild, et al., “Structural requirements of olefinic 5-substituted deoxyuridines for antiherpes activity,”J. Med. Chem.,1983, 26, 1252-1257.
Griffin, et al., “Recognition of thymine-adenine base pairs by guanine in a pyrimidine triple helix motif,”Science,1989, 245, 967-971.
Hamaguchi, et al., “The effect of electrolytes on the stability of the deoxyribonuclate helix,”J. Am. Chem. Soc.,1962, 84, 1329-1338.
Home, et al., “Recognition of mixed-sequence duplex DNA by alternate-strand triple-helix formation,”J. Am. Chem. Soc.,1990, 112, 2435-2437.
Hutton, James R., “Renaturation kinetics and thermal stability of DNA in aqueous solutions of formamide and urea,”Nuc. Acids Res.,Oct. 1977, 3537-3555.
Iverson, et al., “Nonenzymatic sequence-specific cleavage of single-stranded DNA to nucleotide resolution. DNA methyl thioether probes,”J. Am. Chem. Soc.,1987, 109, 1241-1243.
Knorre, et al., “Reactive oligonucleotide derivatives and sequence-specific modification of nucleic acids,”Biochmie,1985, 67, 785-789.
Krawczyk, et al., “Oligonucleotide-mediated triple helix formation using an N[3]-protonated deoxycytidine analog exhibiting pH-independent binding within the physiological range,”Proc. Natl. Acad. Sci.,1992, 89, 37610-3764.
Lee, et al., “Interaction of psoralen-derivatized oligodexoyribonucleoside methylphosphonates with single-stranded DNA,”Biochem,1988, 27, 3197-3203.
Lee, et al., “Poly(pyrimidine) poly(purine) synthetic DNAs containing ???,”Nuc. Acids Res.,1984, 12, 6603-6614.
Maher, et al., “Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation,”Science,1989, 245, 725-730.
Matteucci, et al., “Synthesis and crosslinking properties of a deoxyoligonucleotide containing N[6],N[6]-ethanodeoxyadenosine,”Tet. Letts.,1987, 28, 2469-2472.
Matthews, et al., “Analytical strategies for the use of DNA probes,”Anal. Biochem.,1988, 169, 1-25.
Meyer, et al., “Efficient specific cross-linking and cleavage of DNA by stable, synthetic complementary oligodeoxynucleotides,”J. Am. Chem. Soc.,1989, 111, 8517-8519.
Moser, et al., “Sequence-specific cleavage of double helical DNA by triple helix formation,”Science,1987, 238, 645-650.
Murakami, et al., “Highly sensitive detection of DNA using enzyme-linked DNA-probe. 1. Colorimetric and fluorometric dete
Froehler Brian
Gutierrez Arnold J.
Jones Robert J.
Matteucci Mark
Pudlo Jeff
ISIS Patent Department
ISIS Pharmaceuticals Inc.
Riley Jezia
LandOfFree
Enhanced triple-helix and double-helix formation with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced triple-helix and double-helix formation with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced triple-helix and double-helix formation with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3395446